Management of Staphylococcus aureus bacteraemia (SAB) in the oncology patient: Further evidence supports prompt removal of central venous catheters and shorter duration of intravenous antimicrobial therapy

• Egile Nagusiak: Colum P. Dunne (Egilea), Phelim Ryan (Egilea), Roisin Connolly (Egilea), Suzanne S. Dunne (Egilea), Mohammed A. Kaballo (Egilea), James Powell (Egilea), Bernie Woulfe (Egilea), Nuala H. O'Connell (Egilea), Rajnish K. Gupta (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Summary: Background: Staphylococcus aureus bacteraemia (SAB) is associated with relatively high risk of complications and high levels of mortality. Internationally, SAB management guidelines lack consensus and especially so regarding oncology patients. This is likely a reflection of insufficient ran...